varivax ii powder for solution
merck frosst canada & cie, merck frosst canada & co. - varicella-zoster virus vaccine live attenuated (oka/merck strain) - powder for solution - 1350unit - varicella-zoster virus vaccine live attenuated (oka/merck strain) 1350unit - vaccines
zostavax
merck sharp & dohme b.v. - varicella-zoster virus (live, attenuated) - herpes zoster; immunization - viral vaccines - zostavax is indicated for prevention of herpes zoster ('zoster' or shingles) and herpes-zoster-related post-herpetic neuralgia. zostavax is indicated for immunisation of individuals 50 years of age or older.,
zostavax
msd pharma (singapore) pte. ltd. - live attenuated oka/merck strain of varicella-zoster virus - injection, powder, lyophilized, for suspension - 19,400 pfu/dose
zostavax zoster virus vaccine live min 19400 pfu/0.65ml powder for injection vial with pre-filled diluent vial
merck sharp & dohme (australia) pty ltd - live varicella vaccine, quantity: 19400 pfu - injection, powder for - excipient ingredients: dibasic sodium phosphate; sodium chloride; urea; potassium chloride; sucrose; monobasic potassium phosphate; monosodium glutamate monohydrate; hydrolysed gelatin - zostavax is indicated for the prevention of herpes zoster (shingles) in individuals 50 years of age and older. zostavax is indicated for the prevention of postherpetic neuralgia (phn) and for reduction of acute and chronic zoster-associated pain in individuals 60 years of age and older.
zostavax zoster virus vaccine live min 19400 pfu/0.65ml powder for injection vial with pre-filled diluent syringe
merck sharp & dohme (australia) pty ltd - live varicella vaccine, quantity: 19400 pfu - injection, powder for - excipient ingredients: monosodium glutamate monohydrate; sodium chloride; sucrose; hydrolysed gelatin; dibasic sodium phosphate; monobasic potassium phosphate; potassium chloride; urea - zostavax is indicated for the prevention of herpes zoster (shingles) in individuals 50 years of age and older. zostavax is indicated for the prevention of postherpetic neuralgia (phn) and for reduction of acute and chronic zoster-associated pain in individuals 60 years of age and older.
zostavax zoster virus vaccine live min 19400 pfu/0.65ml powder for injection vial
merck sharp & dohme (australia) pty ltd - live varicella vaccine, quantity: 19400 pfu - injection, powder for - excipient ingredients: monosodium glutamate monohydrate; monobasic potassium phosphate; urea; sodium chloride; dibasic sodium phosphate; hydrolysed gelatin; potassium chloride; sucrose - zostavax is indicated for the prevention of herpes zoster (shingles) in individuals 50 years of age and older. zostavax is indicated for the prevention of postherpetic neuralgia (phn) and for reduction of acute and chronic zoster-associated pain in individuals 60 years of age and older.
varivax iii powder for solution
merck canada inc - varicella virus live attenuated (oka/merck strain) - powder for solution - 1350unit - varicella virus live attenuated (oka/merck strain) 1350unit - vaccines
zostavax [ zoster vaccine live (oka/merck), msd]
merck sharp & dohme (malaysia) sdn bhd - zoster vaccine live oka/merck -
proquad
merck sharp & dohme (new zealand) limited - measles vaccine 1000 tcid50 (edmonston b strain (3 log per dose)); mumps virus, jeryl-lynn strain 19952 tcid50 (b level (4.3 log per dose)); rubella virus, wistar ra27/3 strain 1000 tcid50 ((3 log per dose) ); varicella vaccine 9772 pfu (oka/merck strain (3.99 log per dose)); - injection with diluent - 0.5 ml - active: measles vaccine 1000 tcid50 (edmonston b strain (3 log per dose)) mumps virus, jeryl-lynn strain 19952 tcid50 (b level (4.3 log per dose)) rubella virus, wistar ra27/3 strain 1000 tcid50 ((3 log per dose) ) varicella vaccine 9772 pfu (oka/merck strain (3.99 log per dose)) excipient: dibasic potassium phosphate dibasic sodium phosphate gelatin minimum essential medium eagle medium 199 monosodium glutamate phenolsulfonphthalein potassium chloride sodium bicarbonate sodium chloride sorbitol sucrose urea water for injection - proquad is indicated for vaccination against measles, mumps, rubella, and varicella in individuals 12 months through 12 years of age.
varivax powder and solvent for suspension for injection
merck sharp & dohme limited - varicella virus oka/merck strain (live, attenuated) - powder and solvent for suspension for injection - varicella virus oka/merck strain (live, attenuated) - vaccines